Cargando…
Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis
Autores principales: | Khan, Umair T., Racu‐Amoasii, Igor, Arumainathan, Arvind, Meswani, Ushma, Pettitt, Andrew R., Menon, Geetha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282794/ https://www.ncbi.nlm.nih.gov/pubmed/29984820 http://dx.doi.org/10.1111/bjh.15489 |
Ejemplares similares
-
Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022) -
CD56 positive central nervous system plasmacytosis in a patient with refractory CD56 negative primary plasma cell leukaemia
por: Yong, Jun, et al.
Publicado: (2021) -
Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021) -
Persistent polyclonal B‐cell lymphocytosis: Illustration of the great mimicker of low‐grade B‐cell lymphoma
por: Nkosi, Dingani, et al.
Publicado: (2022) -
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
por: Khan, Umair Tahir, et al.
Publicado: (2021)